Tag: Respiratory Problems: Misc.
Current Surge Noted in RSV Infection, Especially in Older Children
Greater proportion of children hospitalized in 2022 to 2023 were aged 2 to younger than 5 years and aged 5 to younger than 12 years
RSV in First Year of Life Tied to Risk for Childhood Asthma
Authors say association is age- and severity-dependent
GERD Increases Risk for Idiopathic Pulmonary Fibrosis
However, Mendelian randomization study did not identify reverse effect
FDA Approves First RSV Vaccine
Arexvy was ~82 percent effective in preventing RSV-induced lower respiratory tract infections in adults 60 years of age and older
Disparities Seen in Patient Selection for Extracorporeal Membrane Oxygenation
ECMO use less likely among women, patients with Medicaid, and patients living in the lowest-income neighborhoods
RSVpreF Safe, Effective for Preventing Respiratory Syncytial Virus Illness in Seniors
Findings seen in phase 3 trial of adults aged 60 years and older receiving a single intramuscular injection of RSVpreF vaccine
RSVpreF Vaccine Found to Be Safe, Effective During Pregnancy
Phase 3 trial shows the vaccine is effective against medically attended severe RSV-associated lower respiratory tract illness in infants
Pandemic Disrupted Respiratory Syncytial Virus Season Timing
However, evidence shows the 2022 to 2023 season is a return toward prepandemic seasonality
Racial Disparities Seen for Pulmonary Fibrosis Outcomes
Black patients experience younger age for first hospitalization, lung transplant, and death
Risk for Premature Adult Death Up With Childhood Lower Respiratory Infection
Those with lower respiratory tract infection during early childhood have increased risk for dying from respiratory disease by age 73 years
